Tag: Biotech and Pharma

Kenvue Inc.’s stock fell 2.6% early Thursday, after the consumer-health business spun out from Johnson & Johnson last year missed revenue estimates for the fourth quarter and offered soft guidance for 2024.

AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it reported fourth-quarter core earnings per share below expectations on higher costs, sending the stock lower.

Eli Lilly reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, Mounjaro.

Novo Holdings, parent of Novo Nordisk (NOVOb.CO), opens new tab, will buy contract drugmaker Catalent (CTLT.N), opens new tab for $11.5 billion in cash to help meet the strong demand for its popular weight-loss drug Wegovy, the companies said on Monday.

Merck reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.

The maker of weight loss drug Wegovy and diabetes drug Ozempic reported an increase in sales of 31% in Danish kroner and 36% at constant exchange rates to 232.3 billion kroner ($33.71 billion).

Pfizer posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business performed better than expected.

Shares in Bayer dropped as much as 5.7% on Monday after the embattled German company was ordered to pay $2.25 billion in damages, the highest amount yet in its ongoing litigation linked to an alleged carcinogenic effect of its Roundup weedkiller.

Στο πλαίσιο της συμφωνίας, η FAMAR θα αναλάβει, ως αποκλειστικός πάροχος, την παραγωγή των αναλγητικών φαρμακευτικών προϊόντων Lonarid N® και Lonalgal® της Lavipharm.

Johnson & Johnson reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations.

Johnson & Johnson said on Monday it had agreed to buy drug developer Ambrx Biopharma  for $2 billion to gain access to drugs that belong to a class of targeted cancer therapies which have drawn interest from other drugmakers.

Eli Lilly and Co on Thursday launched a website to help people with obesity get prescriptions through telehealth providers and provide home delivery of its weight-loss medicines.

Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash.

 Bristol Myers Squibb  on Friday agreed to buy Karuna Therapeutics for $14 billion, gaining a promising experimental schizophrenia drug to help power growth as patents on its older therapies expire later this decade.

Moderna on Thursday unveiled new data from a continuing early-stage trial of the personalized cancer treatment it is testing with Merck, saying that the updated results help build the case that the drug works.

Dec 13 (Reuters) – Pfizer on Wednesday forecast 2024 revenue and profit below Wall Street expectations, sending its shares down 7% in premarket trading even as it raised cost-cut target by $500 million.

Icosavax stock soared 47% in Tuesday premarket trading after the Seattle-based vaccine developer reached a deal to be acquired by pharmaceutical giant AstraZeneca.

Dec 6 (Reuters) – AbbVie said on Wednesday it would buy Cerevel Therapeutics , a developer of drugs for neurological conditions, for about $8.7 billion in a bid to replace revenue as its arthritis drug Humira faces a raft of new competition.

Πολύ πιθανή η απόκτηση ενός ακόμη ιδιαίτερα γνωστού προϊόντος σε σχετικά σύντομο χρονικό διάστημα, τονίζουν κύκλοι της εταιρείας. Υψηλές οι προσδοκίες για το 2024.

Johnson & Johnson stock was edging higher after the pharmaceutical and medical-device company shared its long-term financial outlook.